Kissei Pharmaceutical Co., Ltd.
Notice Regarding Change of Representative Director
Keiji Miyazawa is scheduled to assume office as Representative Director, President, and Chief Operating Officer (COO) on June 23, 2026. He holds 4,407 shares.
Key Figures
- Scheduled Appointment Date: 2026-06-23
- New Representative Director, President and COO: Keiji Miyazawa
- Number of Shares Held: 4,407 shares
AI要約
Overview of Change in Representative Director
Kissei Pharmaceutical Co., Ltd. resolved at the Board of Directors meeting on April 24, 2026, to appoint a new Representative Director. Keiji Miyazawa is scheduled to assume the position of Representative Director, President, and Chief Operating Officer (COO) as part of strengthening the management structure to realize the Mid-Term Management Plan Beyond 80. The formal decision will be made at the Ordinary General Meeting of Shareholders and Board of Directors meeting on June 23, 2026.
Profile and Shareholding Status of the New Representative Director
Keiji Miyazawa was born on April 14, 1967, and joined the company in April 1993. Since then, he has held key positions in the Research Division and has served as Director of the Research Division and KISSEI AMERICA, INC. since June 2022. He currently holds 4,407 shares. The scheduled appointment date is June 23, 2026.
Kissei Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
